Stock 1952 EVEREST MEDICINES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Everest Medicines Limited

Equities

1952

KYG3224E1061

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:34 2024-06-21 EDT 		5-day change 1st Jan Change
19.8 HKD -1.00% Intraday chart for Everest Medicines Limited -2.22% -5.26%
06-10 Transcript : Everest Medicines Limited Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 09:20 AM
05-14 Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer
CI
Everest Medicines Limited Announces Board Changes
CI
Everest Medicines Limited Announces Directorate Changes
CI
Everest Medicines Appoints Mike Berry as Chief Technology Officer
CI
Everest Medicines COO Resigns
MT
Everest Medicines Limited Announces Resignation of Xiaofan Zhan as an Executive Director and the Chief Operating Officer
CI
Everest Medicines Limited Announces Board Changes
CI
Everest Medicines Names CEO
MT
Everest Medicines Appoints Rogers Yongqing Luo as Chief Executive Officer
CI
Everest Medicines Appoints Rogers Yongqing Luo as an Executive Director
CI
Everest Medicines CEO Steps Down
MT
Everest Medicines Limited Announces Chief Executive Officer Changes
CI
Everest Medicines Limited Announces Resignation of Kerry Blanchard as A Member of the Board of Directors
CI
Everest Medicines Limited Appoints Leah Liu as Joint Company Secretary
CI
Everest Medicines Limited Announces Resignation of Ms. Yin Yin as Joint Company Secretary
CI
Everest Medicines : Appoints Former J&J Exec as Chief Scientific Officer
MT
Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer
CI
Everest Medicines : Appoints Chief Commercial Officer; Shares Tumble 4%
MT
Everest Medicines Limited Appoints Kevin Guo as Chief Commercial Officer
CI
Everest Medicines Limited Appoints Lan Kang as Non- Executive Director, with Effect from December 22, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1952 Stock
  4. News Everest Medicines Limited
  5. Insiders